The precision-cell selection biotechnology approach that Orca Bio has developed not only has the potential to solve cancer and relapses, but also hundreds of diseases in the future. Let’s dive into the deep end with Ivan Dimov, PhD engineer, CEO, and cofounder of Orca Bio.
Cancer May No Longer Be The World’s Scariest Word, Thanks To This Good Unicorn
